VIVOSTART
Live / Applied — Fourth extension granted (statement of use) (as of 02 Dec 2025)
What this means for you
Not registered yet, but its 06 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97490617
- Mark type
- Stylized text
- Filed
- 06 Jul 2022
- Published for opposition
- 10 Oct 2023
- Attorney of record
- Chun T. Wright
Goods and services
- Class 001 — Chemicals: Cells, sub-cellular fractions, antibodies, reagents and culture media for scientific, laboratory, and research use; Immune cells isolated from leukapheresis collections by immunomagnetic or density gradient separation from normal, healthy human donors for scientific, laboratory, and research use; Human AB serum derived from either plasma or whole blood from normal, healthy male human donors with AB blood type for scientific, laboratory, research, and further manufacturing use
- Class 039 — Transportation and storage services: Distribution services, namely, delivery of cells, sub-cellular fractions, antibodies, reagents, culture media, and biological tissue, namely, immune cells, bone marrow, and pooled serum from either plasma or whole blood
- Class 042 — Scientific and technological services: Manufacturing and processing of cells in the field of cell therapies for medical and scientific research; Bone marrow aspiration for medical and scientific research; Research and development services in the field of cell therapies; Custom production and manufacture of advanced therapeutics such as cell and gene therapies for others for medical and scientific research; Leukapheresis collections from normal, healthy human donors for use as a source material for manufacturing and processing of cells for laboratory, medical and scientific research; Cell therapy services, namely, manufacturing and processing of Human AB serum and leukapheresis material for human biotherapies and in vivo therapies for laboratory, medical and scientific research; Medical services for cell sampling and isolation, namely, leukapheresis medical treatment services for laboratory, medical and scientific research
Owner
- BioIVT Holdings, LLC, Westbury, NY, US
- BioIVT Holdings, LLC, Westbury, NY, US
Prosecution history
- 26 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2025 — SOU EXTENSION 4 GRANTED
- 02 Dec 2025 — SOU EXTENSION 4 FILED
- 02 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2025 — SOU EXTENSION 3 GRANTED
- 22 May 2025 — SOU EXTENSION 3 FILED
- 22 May 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2024 — SOU EXTENSION 2 GRANTED
- 26 Nov 2024 — SOU EXTENSION 2 FILED
- 26 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED